Fuso Pharmaceutical Industries (4538) · FactUpdated full-year gains on sales of investment securities
Recognition of gain on sale of investment securities
First written in FY2021-Q2. 4 of 15 entries say "Restated". Latest entry: FY2026.
15entries
7years
0from disclosures
How it moved
Same theme, other companies
Recognition of gains on sales of investment securities and shares in affiliated companiesA theme 314 companies write about · 1 as a headwind · 336 as a tailwind
84 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 182 companies compared. The sentences above are computed from all 182.Comparing 200 of the theme's 340 threads.Full recordFilings, disclosures and news, newest first
- FY2026Updated full-year gains on sales of investment securitiesAnnual report
「Gain (loss) on sale of investment securities (△ indicates a gain) - △ 91」
The Company recorded a gain on sale of investment securities of ¥91 million during the current fiscal year. - FY2026-H1Updated the loss on sale of investment securities for the interim periodAnnual report
「Loss on sale of investment securities - 26」
The Company recorded a loss on sale of investment securities of ¥26 million as an extraordinary loss during the current interim accounting period. - FY2025Updated full-year gains on sales of investment securitiesAnnual report
「Gain (loss) on sale of investment securities (△ indicates a gain) △ 39 -」
The Company did not record a gain on sale of investment securities during the current fiscal year, which therefore fell to zero from ¥39 million in the same period of the previous year. - FY2025-H1Updated the gain on sale of investment securities for the interim periodAnnual report
「Gain on sale of investment securities 39 -」
The Company did not record a gain on sale of investment securities during the current interim accounting period, a decrease from ¥39 million in the same period of the previous year. - FY2024RestatedAnnual report
「Gain (loss) on sale of investment securities (△ indicates a gain) △ 39」
The Company recorded a gain on sale of investment securities of ¥39 million during the current fiscal year. - FY2024-Q3RestatedAnnual report
「Gain on sale of investment securities - 39」
The gain on sale of investment securities for the cumulative period of the third quarter of the current fiscal year was ¥39 million, reconfirming the same amount disclosed cumulatively through the second quarter. - FY2024-Q2Updated the gain on sale of investment securities for the second quarterAnnual report
「Gain on sale of investment securities - 39」
The Company recorded a gain on sale of investment securities of ¥39 million as extraordinary income during the cumulative period of the second quarter of the current fiscal year. - FY2024-Q1Updated gain on sale of investment securities for the first quarterAnnual report
「Gain on sale of investment securities - 39」
The Company recorded a gain on sale of investment securities of ¥39 million as extraordinary income during the cumulative period of the first quarter of the current fiscal year. - FY2023Updated full-year gains on sales of investment securitiesAnnual report
「Gain (loss) on sale of investment securities (△ indicates a gain) - △ 138」
The company recognized a ¥138 million gain on the sale of investment securities for FY2023. - FY2023-Q3RestatedAnnual report
「Gain on sale of investment securities - 138」
The gain on the sale of investment securities for the cumulative third quarter was ¥138 million, with no amount recognized in the same period of the previous year. - FY2023-Q2Updated gain on sale of investment securities for the first halfAnnual report
「Gain on sale of investment securities - 138」
The company recognized a ¥138 million gain on the sale of investment securities as non-operating income during the cumulative second quarter. - FY2023-Q1Updated gain on sale of investment securities for the first quarterAnnual report
「Gain on sale of investment securities - 80」
The company recognized an ¥80 million gain on the sale of investment securities as non-operating income during the cumulative first quarter. No amount was recognized in the same period of the previous year. - FY2021Updated full-year gains on sales of investment securitiesAnnual report
「Gain (loss) on sale of investment securities (△ indicates a gain) △38」
The FY2021 full-year statement of cash flows reports a ¥38 million gain on the sale of investment securities. - FY2021-Q3RestatedAnnual report
「Gain on sale of investment securities - 38」
The company reconfirms that it recognized a ¥38 million gain on the sale of investment securities as extraordinary income during the cumulative third quarter. - FY2021-Q2First statedAnnual report
「Gain on sale of investment securities - 38」
The company recognized a ¥38 million gain on the sale of investment securities as extraordinary income during the cumulative second quarter.